Inspirna, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.rgenix.com
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
- Conditions
- Colorectal CancerMetastatic Colon Cancer
- Interventions
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Inspirna, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT05983367
- Locations
- 🇧🇪
Imelda Ziekenhuis, Bonheiden, Antwerpen, Belgium
🇧🇪Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Brussels Capital Region, Belgium
🇧🇪Institut Jules Bordet, Anderlecht, Belgium
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer MetastaticColorectal NeoplasmsGastric CancerGastrointestinal CancerGastrointestinal NeoplasmsColorectal CancerKRAS Mutation-Related TumorsColorectal CarcinomaGastric NeoplasmCRC
- Interventions
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Inspirna, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT03597581
- Locations
- 🇺🇸
Arizona Oncology Associates, PC - HAL, Prescott Valley, Arizona, United States
🇺🇸Arizona Oncology Associates, PC - HOP E, Tucson, Arizona, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
- Conditions
- Endometrial CancerEndometrial Cancer RecurrentLung Cancer RecurrentLung CancerNon-small Cell Lung Cancer MetastaticNon-small Cell Carcinoma
- Interventions
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Inspirna, Inc.
- Target Recruit Count
- 146
- Registration Number
- NCT02922764
- Locations
- 🇺🇸
Arizona Oncology, Tucson, Arizona, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States